cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Celcuity Inc
1 own
2 watching
Current Price
$9.4
$-0.22
(-2.29%)
logo-celc
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
140.46M
52-Week High
52-Week High
14.402
52-Week Low
52-Week Low
4.81
Average Volume
Average Volume
0.09M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization140.46M
icon52-Week High14.402
icon52-Week Low4.81
iconAverage Volume0.09M
iconDividend Yield--
iconP/E Ratio--
What does the Celcuity Inc do?
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company s CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.
Read More
How much money does Celcuity Inc make?
News & Events about Celcuity Inc.
PR Newswire
1month ago
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Celcuity Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Celcuity Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors...
Accesswire
1month ago
MINNEAPOLIS, MN / ACCESSWIRE / December 12, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company, today announced the closing of its private placement, resulting in gross proceeds of approximately $100 million, before deducting placement agent fees and other expenses. The...
Accesswire
1month ago
High response rates and encouraging median progression free survival rates were observed in patients regardless of PIK3CA mutation statusMedian progression free survival (PFS) of 42.3 months was reported for patients who were treatment naïve in the advanced settingMINNEAPOLIS, MN...
Accesswire
2 months ago
MINNEAPOLIS, MN / ACCESSWIRE / November 22, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targeted therapies for cancer treatment, today announced that an abstract accepted for a Spotlight Poster presentation at the 2022 San Antonio Breast...
Accesswire
3 months ago
MINNEAPOLIS, MN/ ACCESSWIRE / November 3, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targeted therapies for a number of different cancers, today announced that it will release its financial results for the third quarter 2022 after the stock...
Frequently Asked Questions
Frequently Asked Questions
What is Celcuity Inc share price today?
plus_minus_icon
Can Indians buy Celcuity Inc shares?
plus_minus_icon
How can I buy Celcuity Inc shares from India?
plus_minus_icon
Can Fractional shares of Celcuity Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Celcuity Inc stocks?
plus_minus_icon
What is today’s traded volume of Celcuity Inc?
plus_minus_icon
What is today’s market capitalisation of Celcuity Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Celcuity Inc?
plus_minus_icon
What percentage is Celcuity Inc down from its 52-Week High?
plus_minus_icon
What percentage is Celcuity Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$9.4
$-0.22
(-2.29%)
logo-celc
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00